Dec 19, 2014 at 12:27 | Source: CNBC-TV18
Kiran Mazumdar Shaw said economy needs some urgent boost. Government must come out with short-term measures that will accelerate economic growth.
Dec 19, 2014 at 08:56 | Source: Moneycontrol.com
CLSA sees limited near triggers for Biocon's valuation gap to narrow with peers
Dec 15, 2014 at 10:10 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma sector will be getting astrological support and advises buying Glenmark Pharma, Aurobindo Pharma, Dr Reddy's Labs, Divis Labs, Biocon, Cadila Healthcare, Torrent Pharma and Ipca Labs.
Dec 15, 2014 at 08:35 | Source: CNBC-TV18
TCS | ING Vysya Bank | Oil India | ONGC | Coal India | GMR Infrastructure | Colgate | Ranbaxy Labs | Biocon | Financial Technologies | Sesa Sterlite | Siemens | HDFC and Jindal Stainless are stocks, which are in the news today.
Dec 09, 2014 at 16:35 | Source: CNBC-TV18
Getting an approval for the product for all the four areas i.e, ankylosing spondylitis, rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis is a big achievement for Cadila said Vikas Dandekar.
Dec 05, 2014 at 15:33 | Source: CNBC-TV18
According to Kunal Bothra of LKP Securities, Biocon may touch Rs 484.
Dec 05, 2014 at 09:46 | Source: CNBC-TV18
CK Narayan, Managing Director of Growth Avenues recommends buying Kotak Mahindra Bank.
Dec 05, 2014 at 09:21 | Source: CNBC-TV18
CK Narayan says one must look at trading those companies that have news element attached to it. According to him Kotak Mahindra Bank is one such stock which has both momentum and news on back of it and so it should be on the traders list.
Dec 04, 2014 at 13:27 | Source: CNBC-TV18
Gaurav Bissa, Derivatives Analyst at LKP Securities feels that Biocon may test Rs 490.
Dec 04, 2014 at 12:54 | Source: CNBC-TV18
Watch the interview of Gaurav Bissa, Derivatives Analyst at LKP Securities with Latha Venkatesh & Sumaira Abidi on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.